• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cue Biopharma, Inc. - Common Stock (NQ:CUE)

    0.8363 +0.0536 (+6.85%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 328,236
    Open 0.7507
    Bid (Size) 0.7945 (2)
    Ask (Size) 0.8600 (17)
    Prev. Close 0.7827
    Today's Range 0.7507 - 0.8525
    52wk Range 0.4500 - 2.260
    Shares Outstanding 44,959,548
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Discover the top movers in Monday's pre-market session.
    Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
    Via Chartmill

    Performance

    YTD
    -23.3%
    -23.3%
    1 Month
    -18.8%
    -18.8%
    3 Month
    -30.9%
    -30.9%
    6 Month
    -46.7%
    -46.7%
    1 Year
    -44.2%
    -44.2%

    More News

    Read More
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    What's Going On With Cue Biopharma Shares Tuesday?
    Via Benzinga
    Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Announces Strategic Organizational Transition
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Cue Biopharma Announces Pricing of $12.0 Million Public Offering
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    Cue Biopharma Announces Proposed Public Offering
    From Cue Biopharma, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga

    Frequently Asked Questions

    Is Cue Biopharma, Inc. - Common Stock publicly traded?
    Yes, Cue Biopharma, Inc. - Common Stock is publicly traded.
    What exchange does Cue Biopharma, Inc. - Common Stock trade on?
    Cue Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Cue Biopharma, Inc. - Common Stock?
    The ticker symbol for Cue Biopharma, Inc. - Common Stock is CUE on the Nasdaq Stock Market
    What is the current price of Cue Biopharma, Inc. - Common Stock?
    The current price of Cue Biopharma, Inc. - Common Stock is 0.8363
    When was Cue Biopharma, Inc. - Common Stock last traded?
    The last trade of Cue Biopharma, Inc. - Common Stock was at 04/23/25 04:00 PM ET
    What is the market capitalization of Cue Biopharma, Inc. - Common Stock?
    The market capitalization of Cue Biopharma, Inc. - Common Stock is 37.60M
    How many shares of Cue Biopharma, Inc. - Common Stock are outstanding?
    Cue Biopharma, Inc. - Common Stock has 38M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.